Evidence map›Paper›PMID 24385923›Full record

ArticlePLoS genetics2013

TATN-1 mutations reveal a novel role for tyrosine as a metabolic signal that influences developmental decisions and longevity in Caenorhabditis elegans.

Annabel A Ferguson, Sudipa Roy, Kaitlyn N Kormanik, Yongsoon Kim, Kathleen J Dumas, Vladimir B Ritov, Dietrich Matern, Patrick J Hu, Alfred L Fisher

Abstract read
In one paragraph

Article in PLoS genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Annabel A FergusonDivision of Geriatric Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
Sudipa RoyDepartment of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America ; Center for Healthy Aging, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.
Kaitlyn N KormanikDivision of Geriatric Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
Yongsoon KimLife Sciences Institute, University of Michigan, Ann Arbor, Michigan, United States of America.
Kathleen J DumasLife Sciences Institute, University of Michigan, Ann Arbor, Michigan, United States of America.
Vladimir B RitovDepartment of Environmental and Occupational Health, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
Dietrich MaternBiochemical Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America.
Patrick J HuLife Sciences Institute, University of Michigan, Ann Arbor, Michigan, United States of America ; Departments of Internal Medicine and Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.
Alfred L FisherDepartment of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America ; Center for Healthy Aging, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America ; GRECC, South Texas VA Health Care System, San Antonio, Texas, United States of America.

Funding

CELLULAR AND MOLECULAR BIOLOGY AT MICHIGANT32GM007315 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PUTHENVEEDU, MANOJKUMAR A · 1985 to 2021
$12.8M
Research Training in BiogerontologyT32AG000114 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCOTT PLETCHER · 1985 to 2026
$12.4M
Effects of insulin-like signaling, aging, and ubiquinone on C. elegans muscleR01AG044768 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI FISHER, ALFRED L · 2012 to 2016
$1.6M
Regulation on of the AIRAP/aip-1 pathway by metabolic stressR01ES017761 · NIEHS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI FISHER, ALFRED L · 2010 to 2014
$1.1M
Dopamine, Tryosine, and their Metabolites in Aging in Neurodegenerative DiseaseK08AG028977 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FISHER, ALFRED L · 2006 to 2009
$756k
Novel regulators of FoxO transcription factorsR56DK078183 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HU, PATRICK J · 2008 to 2009
$456k
daf-12 Target Genes during C. elegans agingK08AG024414 · NIA · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI FISHER, ALFRED L · 2004 to 2005
$233k
NIA NIH HHS K08 AG024414NIA NIH HHS K08 AG028977NIA NIH HHS K08 AG24414NIA NIH HHS R01 AG044768NIA NIH HHS T32 AG000114NIDDK NIH HHS R56 DK078183NIEHS NIH HHS R01 ES017761NIGMS NIH HHS T32 GM007315
6 · The paper itself

Abstract

Recent work has identified changes in the metabolism of the aromatic amino acid tyrosine as a risk factor for diabetes and a contributor to the development of liver cancer. While these findings could suggest a role for tyrosine as a direct regulator of the behavior of cells and tissues, evidence for this model is currently lacking. Through the use of RNAi and genetic mutants, we identify tatn-1, which is the worm ortholog of tyrosine aminotransferase and catalyzes the first step of the conserved tyrosine degradation pathway, as a novel regulator of the dauer decision and modulator of the daf-2 insulin/IGF-1-like (IGFR) signaling pathway in Caenorhabditis elegans. Mutations affecting tatn-1 elevate tyrosine levels in the animal, and enhance the effects of mutations in genes that lie within the daf-2/insulin signaling pathway or are otherwise upstream of daf-16/FOXO on both dauer formation and worm longevity. These effects are mediated by elevated tyrosine levels as supplemental dietary tyrosine mimics the phenotypes produced by a tatn-1 mutation, and the effects still occur when the enzymes needed to convert tyrosine into catecholamine neurotransmitters are missing. The effects on dauer formation and lifespan require the aak-2/AMPK gene, and tatn-1 mutations increase phospho-AAK-2 levels. In contrast, the daf-16/FOXO transcription factor is only partially required for the effects on dauer formation and not required for increased longevity. We also find that the controlled metabolism of tyrosine by tatn-1 may function normally in dauer formation because the expression of the TATN-1 protein is regulated both by daf-2/IGFR signaling and also by the same dietary and environmental cues which influence dauer formation. Our findings point to a novel role for tyrosine as a developmental regulator and modulator of longevity, and support a model where elevated tyrosine levels play a causal role in the development of diabetes and cancer in people.

Indexed as

AnimalsAnimals, Genetically ModifiedCaenorhabditis elegansCaenorhabditis elegans ProteinsForkhead Transcription FactorsGene Expression Regulation, DevelopmentalGreen Fluorescent ProteinsHumansInsulinInsulin-Like Growth Factor ILarvaLongevityMetabolic Networks and PathwaysMutationReceptor, InsulinRNA InterferenceCaenorhabditis elegans Proteinsdaf-16 protein, C elegansForkhead Transcription FactorsGreen Fluorescent ProteinsInsulinInsulin-Like Growth Factor IReceptor, InsulinTranscription FactorsTyrosineTyrosine Transaminase

Identifiers

PMID24385923
PMCPMC3868569

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.